Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sifan Yu

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
JACS Au|December 26, 2025
Harnessing Bone-Liver Crosstalk: A Dual-Action LYTAC Approach for Bone-Specific Accumulation and Liver-Specific Protein Degradation in Bone DisordersYuan Ma, Gubu Amu, Yufei Pan, et al.
Neoplasia (New York, N.Y.)|February 2, 2017
PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of SnailShicong Zhai, Cui Liu, Lichen Zhang, et al.
Journal of Cellular and Molecular Medicine|July 6, 2018
RNF168 facilitates oestrogen receptor ɑ transcription and drives breast cancer proliferationZhenhua Liu, Jinghang Zhang, Juntao Xu, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 14, 2018
SMURF1 facilitates estrogen receptor ɑ signaling in breast cancer cellsHuijie Yang, Na Yu, Juntao Xu, et al.
Acta Pharmaceutica Sinica. B|June 1, 2022
Drug discovery of sclerostin inhibitorsSifan Yu, Dijie Li, Ning Zhang, et al.
Research (Washington, D.C.)|July 15, 2026
Dual-Mechanism Aptamer-Drug Complex Overcomes Paclitaxel Resistance in Ovarian Cancer via Structural Constraint and Telomerase InhibitionYuan Ma, Zefeng Chen, Xinyang Shen, et al.
Oncotarget|November 5, 2017
SHARPIN stabilizes estrogen receptor α and promotes breast cancer cell proliferationTing Zhuang, Sifan Yu, Lichen Zhang, et al.
Acta Pharmaceutica Sinica. B|July 15, 2026
AI-powered therapeutic aptamer drug discovery: Targeting the CT-domain of CTGF for duchenne muscular dystrophyShanshan Yao, Xin Yang, Meishen Ren, et al.
Molecular Therapy. Nucleic Acids|February 3, 2025
DeepAptamer: Advancing high-affinity aptamer discovery with a hybrid deep learning modelXin Yang, Chi Ho Chan, Shanshan Yao, et al.
Molecular Therapy. Nucleic Acids|March 6, 2024
Unique quinoline orientations shape the modified aptamer to sclerostin for enhanced binding affinity and bone anabolic potentialAmu Gubu, Yuan Ma, Sifan Yu, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
JACS Au|December 26, 2025
Harnessing Bone-Liver Crosstalk: A Dual-Action LYTAC Approach for Bone-Specific Accumulation and Liver-Specific Protein Degradation in Bone DisordersYuan Ma, Gubu Amu, Yufei Pan, et al.
Neoplasia (New York, N.Y.)|February 2, 2017
PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of SnailShicong Zhai, Cui Liu, Lichen Zhang, et al.
Journal of Cellular and Molecular Medicine|July 6, 2018
RNF168 facilitates oestrogen receptor ɑ transcription and drives breast cancer proliferationZhenhua Liu, Jinghang Zhang, Juntao Xu, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 14, 2018
SMURF1 facilitates estrogen receptor ɑ signaling in breast cancer cellsHuijie Yang, Na Yu, Juntao Xu, et al.
Acta Pharmaceutica Sinica. B|June 1, 2022
Drug discovery of sclerostin inhibitorsSifan Yu, Dijie Li, Ning Zhang, et al.
Research (Washington, D.C.)|July 15, 2026
Dual-Mechanism Aptamer-Drug Complex Overcomes Paclitaxel Resistance in Ovarian Cancer via Structural Constraint and Telomerase InhibitionYuan Ma, Zefeng Chen, Xinyang Shen, et al.
Oncotarget|November 5, 2017
SHARPIN stabilizes estrogen receptor α and promotes breast cancer cell proliferationTing Zhuang, Sifan Yu, Lichen Zhang, et al.
Acta Pharmaceutica Sinica. B|July 15, 2026
AI-powered therapeutic aptamer drug discovery: Targeting the CT-domain of CTGF for duchenne muscular dystrophyShanshan Yao, Xin Yang, Meishen Ren, et al.
Molecular Therapy. Nucleic Acids|February 3, 2025
DeepAptamer: Advancing high-affinity aptamer discovery with a hybrid deep learning modelXin Yang, Chi Ho Chan, Shanshan Yao, et al.
Molecular Therapy. Nucleic Acids|March 6, 2024
Unique quinoline orientations shape the modified aptamer to sclerostin for enhanced binding affinity and bone anabolic potentialAmu Gubu, Yuan Ma, Sifan Yu, et al.
Pageof 6